Samlyn Capital, LLC Aclaris Therapeutics, Inc. Transaction History

Samlyn Capital, LLC

  • $6.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.56 - $10.95 $780,672 - $1.3 Million
119,005 Added 8.85%
1,463,074 $10 Million
Q2 2023

Aug 14, 2023
BUY
$7.89 - $10.64 $2.31 Million - $3.11 Million
292,501 Added 27.82%
1,344,069 $13.9 Million
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $7.43 Million - $18.9 Million
1,051,568 New
1,051,568 $8.51 Million

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $253M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Samlyn Capital, LLC Portfolio

Follow Samlyn Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email